Akso Health (AHG) Notes Payables (2021 - 2024)

Akso Health (AHG) has reported Notes Payables for 3 consecutive years, with $4.6 million the latest figure, recorded in Q3 2024.

• Quarterly Notes Payables rose 1227.28% year-over-year to $4.6 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $4.6 million (up 1227.28% YoY) and the FY2021 annual result came in at $10.0 million, changed N/A from the prior year.
• Notes Payables grew to $4.6 million in Q3 2024 per AHG's latest filing, from $350000.0 in the prior quarter.
• Over the last five years, Notes Payables for AHG reached as high as $10000.0 billion in Q3 2021 and fell as low as $350000.0 in Q3 2023.
• A 3-year average of $2500.0 billion and a median of $7.3 million in 2021 frame the typical range for Notes Payables.
• The largest YoY upside for Notes Payables was 1227.28% in 2024 against a maximum downside of 1227.28% in 2024.
• Year by year, Notes Payables stood at $10000.0 billion in 2021, then slumped by 100.0% to $350000.0 in 2023, then surged by 1227.28% to $4.6 million in 2024.
• According to Business Quant data, Notes Payables over the past three periods registered $4.6 million, $350000.0, and $10000.0 billion for Q3 2024, Q3 2023, and Q3 2021 respectively.